Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation
Identifying the risk factors for carbapenem-resistant Enterobacterales (CRE) bacteremia in cancer and hematopoietic stem cell transplantation (HSCT) patients would allow earlier initiation of an appropriate empirical antibiotic treatment. This is a prospective multicenter observational study in pati...
Saved in:
Similar Items
-
Chagas disease reactivation: cutaneous manifestations in a transplanted patient
by: Maria Guillermina Ferraresso, et al.
Published: (2018) -
Prenatal risk factors for selected congenital anomalies development: a case-control pilot study in postpartum women from Argentina
by: Carlina Leila Colussi, et al.
Published: (2023) -
A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021) -
Pandemia de COVID-19. Uso de equipos de protección personal y ergonomía en odontología// COVID-19 pandemic. Use of personal protective equipment and ergonomics in dentistry
by: Maria Cristina Tula
Published: (2021) -
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012-2018
by: Diego Faccone, et al.
Published: (2020)